title: Medical abortion in primary care: pitfalls and benefits.
abstract: We describe five pitfalls of medical abortion: ectopic pregnancy not terminated after misoprostol, but without negative side-effects; long-term vaginal blood loss with suspicious retained products which disappeared spontaneously; a patient with uterus myomatatosus with severe pain and retained products in the uterus; repetition of misoprostol because of retained products in the uterus after two weeks and an allergic reaction to methotrexate. Despite these pitfalls, there are enough benefits to consider medical abortion with methotrexate and misoprostol as a safe method with a high success rate of more than 91% and a good alternative for surgical abortion. An invasive procedure is not necessary, there are no long-term complications and it can be performed at an earlier stage, which makes it more acceptable in society. In Curaçao, where abortion is legally restricted, medical abortion is performed with methotrexate and misoprostol. In countries where abortion is legal, mifepristone and misoprostol are the first choice.
authors.affiliation: adrianaboersma@hotmail.com
authors.forename: A A
authors.initials: AA
authors.lastname: Boersma
authors.forename: B
authors.initials: B
authors.lastname: Meyboom-de Jong
mesh_terms: D000019:Abortifacient Agents / Q000008:administration & dosage*; D000028:Abortion, Induced / Q000379:methods*; D000282:Administration, Intravaginal; D000328:Adult; D004107:Dilatation and Curettage; D005260:Female; D006801:Humans; D018231:Leiomyomatosis / Q000150:complications / Q000000981:diagnostic imaging; D016595:Misoprostol / Q000008:administration & dosage*; D011247:Pregnancy; D011252:Pregnancy Complications, Neoplastic / Q000000981:diagnostic imaging; D017211:Treatment Failure; D014463:Ultrasonography; D055815:Young Adult
chemical_list: D000019:Abortifacient Agents; D016595:Misoprostol